277 related articles for article (PubMed ID: 7490131)
21. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses.
Newman MJ; Wu JY; Gardner BH; Munroe KJ; Leombruno D; Recchia J; Kensil CR; Coughlin RT
J Immunol; 1992 Apr; 148(8):2357-62. PubMed ID: 1373166
[TBL] [Abstract][Full Text] [Related]
22. Class I-restricted presentation occurs without internalization or processing of exogenous antigenic peptides.
Hosken NA; Bevan MJ; Carbone FR
J Immunol; 1989 Feb; 142(4):1079-83. PubMed ID: 2492575
[TBL] [Abstract][Full Text] [Related]
23. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
Adorini L; Ullrich SJ; Appella E; Fuchs S
Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
[TBL] [Abstract][Full Text] [Related]
24. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
26. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
[TBL] [Abstract][Full Text] [Related]
27. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
28. Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo.
Schutze-Redelmeier MP; Gournier H; Garcia-Pons F; Moussa M; Joliot AH; Volovitch M; Prochiantz A; Lemonnier FA
J Immunol; 1996 Jul; 157(2):650-5. PubMed ID: 8752913
[TBL] [Abstract][Full Text] [Related]
29. Phagocyte-induced antigen-specific activation of unprimed CD8+ T cells in vitro.
De Bruijn ML; Jackson MR; Peterson PA
Eur J Immunol; 1995 May; 25(5):1274-85. PubMed ID: 7539754
[TBL] [Abstract][Full Text] [Related]
30. Enhanced CTL response by controlled intracellular trafficking of antigen in dendritic cells following DNA vaccination.
Isaji K; Kawase A; Matono M; Guan X; Nishikawa M; Takakura Y
J Control Release; 2009 May; 135(3):227-33. PubMed ID: 19331843
[TBL] [Abstract][Full Text] [Related]
31. MHC class I-restricted presentation of exogenous antigen by thymic antigen-presenting cells in vitro and in vivo.
Grant EP; Rock KL
J Immunol; 1992 Jan; 148(1):13-8. PubMed ID: 1727862
[TBL] [Abstract][Full Text] [Related]
32. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
Hao S; Yuan J; Xiang J
J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of class I and class II MHC-restricted antigen presentation by cytotoxic T lymphocytes specific for an exogenous antigen.
Rock KL; Rothstein L; Fleischacker C; Gamble S
J Immunol; 1992 May; 148(10):3028-33. PubMed ID: 1578128
[TBL] [Abstract][Full Text] [Related]
34. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
35. The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant.
Nikolić-Zugić J; Carbone FR
Eur J Immunol; 1990 Nov; 20(11):2431-7. PubMed ID: 2253683
[TBL] [Abstract][Full Text] [Related]
36. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
Zügel U; Schoel B; Kaufmann SH
J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
[TBL] [Abstract][Full Text] [Related]
37. Dynamic quantification of MHC class I-peptide presentation to CD8+ T cells via intracellular cytokine staining.
Pang KC; Wei JQ; Chen W
J Immunol Methods; 2006 Apr; 311(1-2):12-8. PubMed ID: 16516224
[TBL] [Abstract][Full Text] [Related]
38. Weak base amines can inhibit class I MHC-restricted antigen presentation.
Michalek MT; Benacerraf B; Rock KL
J Immunol; 1991 Jan; 146(2):449-56. PubMed ID: 1987272
[TBL] [Abstract][Full Text] [Related]
39. Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen.
Lee YR; Lee YH; Im SA; Yang IH; Ahn GW; Kim K; Lee CK
Arch Pharm Res; 2010 Nov; 33(11):1859-66. PubMed ID: 21116790
[TBL] [Abstract][Full Text] [Related]
40. Extracellular heat shock protein 90 plays a role in translocating chaperoned antigen from endosome to proteasome for generating antigenic peptide to be cross-presented by dendritic cells.
Oura J; Tamura Y; Kamiguchi K; Kutomi G; Sahara H; Torigoe T; Himi T; Sato N
Int Immunol; 2011 Apr; 23(4):223-37. PubMed ID: 21421737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]